Lee, J. et al. Increased primary cilia in idiopathic pulmonary fibrosis. Mol. Cells. 41, 224–233 (2018).
Villalobos, E. et al. Fibroblast primary cilia are required for cardiac fibrosis. Circulation 140, 2342–2357 (2019).
Teves, M. E. et al. The primary cilium: emerging role as a key player in fibrosis. Curr. Rheumatol. Rep. 21, 29 (2019).
Hosio, M. et al. Primary ciliary signaling in the skin — contribution to wound healing and scarring. Front. Cell Dev. Biol. 8, 578384 (2020).
Kim, E. et al. Aberrant multiciliogenesis in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 67, 561–575 (2022).
Kawasaki, M. et al. Primary cilia suppress the fibrotic activity of atrial fibroblasts from patients with atrial fibrillation in vitro. Sci. Rep. 14, 12470 (2024).
Verma, P. et al. Morphological reprogramming of primary cilia length mitigates the fibrotic phenotype in fibroblasts across diverse fibrotic conditions. J. Cell Sci. 138, jcs264191 (2025).
Wells, R. et al. Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shortening. Arthritis Res. Ther. https://doi.org/10.1186/s13075-026-03826-6 (2026).
Ott, C. M. & Lippincott-Schwartz, J. Design principles of ciliary signaling. J. Cell Sci. 138, jcs264325 (2025).
Sun, S., Fisher, R. L., Bowser, S. S., Pentecost, B. T. & Sui, H. Three-dimensional architecture of epithelial primary cilia. Proc. Natl. Acad. Sci. USA. 116, 9370–9379 (2019).
Ott, C. M. & Mukhopadhyay, S. Taking down the primary cilium: pathways for disassembly in differentiating cells. BioEssays 47, e70060 (2025).
Li, J., Huang, S. & Chen, H. Advances in imaging techniques for mammalian/human ciliated cell’s cilia: insights into structure, function, and dynamics. Biology 14, 521 (2025).
Alzarka, B., Charnaya, O. & Gunay-Aygun, M. Diseases of the primary cilia: a clinical characteristics review. Pediatr. Nephrol. 40, 611–627 (2025).
Li, B., He, Y. Y. & Yang, Z. M. Primary cilia function as hubs for signal transduction. Cell Biosci. 15, 163 (2025).
Saito, M., Otsu, W., Miyadera, K. & Nishimura, Y. Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets. Front. Mol. Biosci. 10, 1232188 (2023).
Wachten, D. & Christensen, S. T. Primary cilia signalling at a glance. J. Cell Sci. 138, jcs264187 (2025).
Corbeil, D., Thamm, K., Karbanová, J., Fargeas, C. A. & Jászai, J. The primary cilium as a multifunctional organelle: emerging roles and unanswered questions. Cell Commun. Signal. 23, 406 (2025).
Hilgendorf, K. I., Myers, B. R. & Reiter, J. F. Emerging mechanistic understanding of cilia function in cellular signalling. Nat. Rev. Mol. Cell Biol. 25, 555–573 (2024).
Keiser, N. W., Cant, E., Sitaraman, S., Shoemark, A. & Limberis, M. P. Restoring ciliary function: gene therapeutics for primary ciliary dyskinesia. Hum. Gene Ther. 34, 821–835 (2023).
Turan, M. G., Orhan, M. E., Cevik, S. & Kaplan, O. I. CiliaMiner: an integrated database for ciliopathy genes and ciliopathies. Database 2023, baad047 (2023).
Liu, C. J. et al. CiliaKB: A comprehensive knowledge base for cilia-associated genes. PLoS Biol. 24, e3003774 (2026).
Ni, H. et al. CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosis. Cell Death Dis. 15, 581 (2024).
Kiesel, P. et al. The molecular structure of mammalian primary cilia revealed by cryo-electron tomography. Nat. Struct. Mol. Biol. 27, 1115–1124 (2020).
Ott, C. M. et al. Ultrastructural differences impact cilia shape and external exposure across cell classes in the visual cortex. Curr. Biol. 34, 2418–2433.e4 (2024).
Wang, Z. et al. Histone deacetylase 6 (HDAC6) in ciliopathies: emerging insights and therapeutic implications. Adv. Sci. 12, e2412921 (2025).
Menco, B. P. & Farbman, A. I. Genesis of cilia and microvilli of rat nasal epithelia during prenatal development. III. Respiratory epithelium surface, including a comparison with the surface of the olfactory epithelium. J. Anat. 152, 145–160 (1987).
Müller et al. Structure, interaction and nervous connectivity of beta cell primary cilia. Nat. Commun. 15, 9168 (2024).
Stevenson, N. L. The factory, the antenna and the scaffold: the three-way interplay between the Golgi, cilium and extracellular matrix underlying tissue function. Biol. Open 12, bio059719 (2023).
Hesketh, S. J., Mukhopadhyay, A. G., Nakamura, D., Toropova, K. & Roberts, A. J. IFT-A structure reveals carriages for membrane protein transport into cilia. Cell 185, 4971–4985.e16 (2022).
Liu, Y., Zhang, Y., Ni, H. & Liu, P. Structure makes a difference: IFT complex in ciliary function and ciliopathy. Cytoskeleton https://doi.org/10.1002/cm.70033 (2025).
Molla-Herman, A. et al. The ciliary pocket: an endocytic membrane domain at the base of primary and motile cilia. J. Cell Sci. 123, 1785–1795 (2010).
Reiter, J. F., Blacque, O. E. & Leroux, M. R. The base of the cilium: roles for transition fibres and the transition zone in ciliary formation, maintenance and compartmentalization. EMBO Rep. 13, 608–618 (2012).
Garcia-Gonzalo, F. R. & Reiter, J. F. Open Sesame: how transition fibers and the transition zone control ciliary composition. Cold Spring Harb. Perspect. Biol. 9, a028134 (2017).
Park, K. & Leroux, M. R. Composition, organization and mechanisms of the transition zone, a gate for the cilium. EMBO Rep. 23, e55420 (2022).
Nakazato, R., Matsuda, Y., Ijaz, F. & Ikegami, K. Circadian oscillation in primary cilium length by clock genes regulates fibroblast cell migration. EMBO Rep. 24, e56870 (2023).
Kobayashi, Y., Hamamoto, A. & Saito, Y. Ciliary length variations impact cilia-mediated signaling and biological responses. J. Biochem. 176, 369–383 (2024).
Zhang, Y. et al. Primary cilium-mediated mechanotransduction in cartilage chondrocytes. Exp. Biol. Med. 248, 1279–1287 (2023).
Kasahara, K. & Inagaki, M. Primary ciliary signaling: links with the cell cycle. Trends Cell Biol. 31, 954–964 (2021).
Zheng, M., Zhou, J. & Wang, Y. Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications. Cancer Biol. Med. 22, 1455–1472 (2025).
Hansen, J. N. et al. Intrinsic heterogeneity of primary cilia revealed through spatial proteomics. Cell 188, 6804–6824 (2025).
Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129–137 (2003).
Wann, A. K. T. et al. Primary cilia mediate mechanotransduction through control of ATP-induced Ca2+ signaling in compressed chondrocytes. FASEB J. 26, 1663–1671 (2012).
Siljee, J. E. et al. Subcellular localization of MC4R is a key determinant of current weight regulation. Nat. Genet. 50, 180–186 (2018).
Wang, Y. et al. The primary cilium is required for MC4R control of food intake and body weight. eLife 10, e66255 (2021).
Takahashi, H., Kasai, T., Miyagawa-Hayashino, A. & Ohara, T. Emerging roles of primary cilia in the pathogenesis of amyotrophic lateral sclerosis. Front. Neurosci. 19, 1688839 (2025).
Ti, H. et al. Primary cilia as mechanosensors in musculoskeletal homeostasis and disease. Pharmacol. Res. 219, 107887 (2025).
Burkhalter, M. D. et al. Imbalanced mitochondrial function provokes heterotaxy via aberrant ciliogenesis. J. Clin. Invest. 129, 2841–2855 (2019).
Miller, E. et al. Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection. Mol. Neurodegener. Adv. 1, 5 (2025).
Chen, X. et al. Reprogramming autoimmune immunity via mitochondrial quality control: mechanisms, biomarkers, and windows for intervention. Int. Immunopharmacol. 188, 117316 (2026).
Moruzzi, N. et al. Mitochondrial impairment and intracellular reactive oxygen species alter primary cilia morphology. Life Sci. Alliance 5, e202201505 (2022).
Lo, C. H. et al. Primary cilia formation requires the Leigh syndrome-associated mitochondrial protein NDUFAF2. J. Clin. Invest. 134, e175560 (2024).
Bangs, F. & Anderson, K. V. Primary cilia and mammalian Hedgehog signaling. Cold Spring Harb. Perspect. Biol. 9, a028175 (2017).
Ho Wei, L., Arastoo, M., Georgiou, I., Manning, D. R. & Riobo-Del Galdo, N. A. Activation of the Gi protein-RHOA axis by non-canonical Hedgehog signaling is independent of primary cilia. PLoS ONE 13, e0203170 (2018).
Horn, A. et al. Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. Arthritis Rheum. 64, 2724–2733 (2012).
Collins, I. & Wann, A. K. T. Regulation of the extracellular matrix by ciliary machinery. Cells 9, 278 https://doi.org/10.3390/cells9020278 (2020).
Wasson, C. W. et al. Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts. Arthritis Res. Ther. 22, 286 (2020).
Singh, S. et al. Endothelial-specific loss of IFT88 promotes endothelial-to-mesenchymal transition and exacerbates bleomycin-induced pulmonary fibrosis. Sci. Rep. 10, 4466 (2020).
Roberts, A. B. et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA. 83, 4167–4171 (1986).
Varga, J., Rosenbloom, J. & Jimenez, S. A. Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem. J. 247, 597–604 (1987).
Bhattacharyya, S., Wei, J. & Varga, J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8, 42–54 (2012).
Clement, C. A. et al. TGF-β signaling is associated with endocytosis at the pocket region of the primary cilium. Cell Rep. 3, 1806–1814 (2013).
Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-β: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325–338 (2016).
Chen, F. et al. The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment. Front. Oncol. 15, 1649179 (2025).
Gencer, S. et al. TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis. Sci. Signal. 10, eaam7464 (2017).
Nguyen, L. M. T. et al. Imbalance of ciliary programs drives fibroblast differentiation and fibrotic signaling in systemic sclerosis. Preprint at bioRxiv https://doi.org/10.64898/2026.02.25.707978 (2026).
Maurice, M. M. & Angers, S. Mechanistic insights into Wnt–β-catenin pathway activation and signal transduction. Nat. Rev. Mol. Cell Biol. 26, 371–388 (2025).
Vuong, L. T. & Mlodzik, M. The complex relationship of Wnt-signaling pathways and cilia. Curr. Top. Dev. Biol. 155, 95–125 (2023).
Strakova, K. et al. Dishevelled enables casein kinase 1-mediated phosphorylation of Frizzled 6 required for cell membrane localization. J. Biol. Chem. 293, 18477–18493 (2018).
Bergmann, C. & Distler, J. H. Canonical Wnt signaling in systemic sclerosis. Lab. Invest. 96, 151–155 (2016).
Fu, M. et al. The Hippo signalling pathway and its implications in human health and diseases. Signal. Transduct. Target. Ther. 7, 376 (2022).
Rausch, V. & Hansen, C. G. The hippo pathway, YAP/TAZ, and the plasma membrane. Trends Cell Biol. 30, 32–48 (2020).
Kim, J. et al. Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking. Nat. Commun. 6, 6781 (2015).
Ma, F. et al. Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis. Nat. Commun. 15, 210 (2024).
Christensen, S. T., Morthorst, S. K., Mogensen, J. B. & Pedersen, L. B. Primary cilia and coordination of receptor tyrosine kinase (RTK) and transforming growth factor β (TGF-β) signaling. Cold Spring Harb. Perspect. Biol. 9, a028167 (2017).
Andrae, J., Gallini, R. & Betsholtz, C. Role of platelet-derived growth factors in physiology and medicine. Genes. Dev. 22, 1276–1312 (2008).
Andrianifahanana, M. et al. Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J. 27, 4444–4454 (2013).
Kitano, H. Biological robustness. Nat. Rev. Genet. 5, 826–837 (2004).
Friedlander, T., Mayo, A. E., Tlusty, T. & Alon, U. Evolution of bow-tie architectures in biology. PLoS Comput. Biol. 11, e1004055 (2015).
Hilliard, S. et al. Bow-tie architectures in biological and artificial neural networks: implications for network evolution and assay design. iScience 26, 106041 (2023).
Itoh, T., Kondo, Y., Aoki, K. & Saito, N. Revisiting the evolution of bow-tie architecture in signaling networks. npj Syst. Biol. Appl. 10, 70 (2024).
Schmid, F. M. et al. IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases. J. Cell Biol. 217, 151–161 (2018).
Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Primers. 1, 15002 (2015).
Abraham, D. J. et al. An international perspective on the future of systemic sclerosis research. Nat. Rev. Rheumatol. 21, 174–187 (2025).
Leask, A., Naik, A. & Stratton, R. J. Back to the future: targeting the extracellular matrix to treat systemic sclerosis. Nat. Rev. Rheumatol. 19, 713–723 (2023).
Distler, J. H. W. et al. Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis. Nat. Rev. Rheumatol. 22, 221–238 (2026).
Ueberall, L. et al. Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Ann. Rheum. Dis. 84, 1865–1876 (2025).
van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P. & van der Kraan, P. Unraveling SSc pathophysiology: the myofibroblast. Front. Immunol. 9, 2452 (2018).
Merkt, W., Zhou, Y., Han, H. & Lagares, D. Myofibroblast fate plasticity in tissue repair and fibrosis: deactivation, apoptosis, senescence and reprogramming. Wound Repair Regen. 29, 678–691 (2021).
Tsou, P. S., Palisoc, P. J., Ali, M., Khanna, D. & Sawalha, A. H. Genome-wide reduction in chromatin accessibility and unique transcription factor footprints in endothelial cells and fibroblasts in scleroderma skin. Arthritis Rheumatol. 73, 1501–1513 (2021).
Roberson, E. D. O. et al. Alterations of the primary cilia gene SPAG17 and SOX9 locus noncoding RNAs identified by RNA-sequencing analysis in patients with systemic sclerosis. Arthritis Rheumatol. 75, 108–119 (2023).
Teves, M. E., Nagarkatti-Gude, D. R., Zhang, Z. & Strauss, J. F. III. Mammalian axoneme central pair complex proteins: broader roles revealed by gene knockout phenotypes. Cytoskeleton 73, 3–22 (2016).
Kazarian, E. et al. SPAG17 is required for male germ cell differentiation and fertility. Int. J. Mol. Sci. 19, 1252 (2018).
Agudo-Rios, C. et al. SPAG17 mediates nuclear translocation of protamines during spermiogenesis. Front. Cell Dev. Biol. 11, 1125096 (2023).
Teves, M. E. et al. Spag17 deficiency results in skeletal malformations and bone abnormalities. PLoS ONE 10, e0125936 (2015).
Sapao, P. et al. Reduced SPAG17 expression in systemic sclerosis triggers myofibroblast transition and drives fibrosis. J. Invest. Dermatol. 143, 284–293 (2023).
Jokl, E. et al. PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis. Cell Rep. 42, 113414 (2023).
Mouawad, J. E. & Feghali-Bostwick, C. The molecular mechanisms of systemic sclerosis-associated lung fibrosis. Int. J. Mol. Sci. 24, 2963 (2023).
Cottin, V. et al. Progressive pulmonary fibrosis: a state-of-the-art review. Eur. Respir. J. 11, 2501557 (2026).
Li, S. et al. Silica perturbs primary cilia and causes myofibroblast differentiation during silicosis by reduction of the KIF3A-repressor GLI3 complex. Theranostics 10, 1719–1732 (2020).
Barsch, F. et al. Physiological and pathophysiological aspects of primary cilia — a literature review with view on functional and structural relationships in cartilage. Int. J. Mol. Sci. 21, 4959 (2020).
Zhou, H., Wu, S., Ling, H., Zhang, C. & Kong, Y. Primary cilia: a cellular regulator of articular cartilage degeneration. Stem Cell Int. 2022, 2560441 (2022).
Segarra-Queralt, M., Crump, K., Pascuet-Fontanet, A., Gantenbein, B. & Noailly, J. The interplay between biochemical mediators and mechanotransduction in chondrocytes: unravelling the differential responses in primary knee osteoarthritis. Phys. Life Rev. 48, 205–221 (2024).
McGlashan, S. R., Cluett, E. C., Jensen, C. G. & Poole, C. A. Primary cilia in osteoarthritic chondrocytes: from chondrons to clusters. Dev. Dyn. 237, 2013–2020 (2008).
Chang, C. F., Ramaswamy, G. & Serra, R. Depletion of primary cilia in articular chondrocytes results in reduced Gli3 repressor to activator ratio, increased Hedgehog signaling, and symptoms of early osteoarthritis. Osteoarthr. Cartil. 20, 152–161 (2012).
Stam, L. B. & Clark, A. L. Chondrocyte primary cilia lengthening and shortening in response to mediators of osteoarthritis: a role for integrin α1β1 and focal adhesions. Osteoarthr. Cartil. Open 5, 100357 (2023).
Wang, Z. et al. IFT88 influences chondrocyte actin organization and biomechanics. Osteoarthr. Cartil. 24, 544–554 (2016).
Fu, S. et al. Mechanical loading inhibits cartilage inflammatory signalling via an HDAC6- and IFT-dependent mechanism regulating primary cilia elongation. Osteoarthr. Cartil. 27, 1064–1074 (2019).
Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316–333 (2020).
Yuan, G., Yang, S. T. & Yang, S. Regulator of G protein signaling 12 drives inflammatory arthritis by activating synovial fibroblasts through MYCBP2/KIF2A signaling. Mol. Ther. Nucleic Acids 31, 197–210 (2023).
Mirrahimi, M. et al. 5′ HOXD genes differentially regulate gene expression of synovial fibroblasts in hand joints. Preprint at bioRxiv https://doi.org/10.1101/2024.12.10.627720 (2024).
Djenoune, L., Berg, K., Brueckner, M. & Yuan, S. A change of heart: new roles for cilia in cardiac development and disease. Nat. Rev. Cardiol. 19, 211–227 (2022).
Yang, Y., Ren, K., Shi, X. & Luan, Y. Primary cilia orchestrate cardiac pathogenesis: a central nexus of remodeling, signaling, and repair. Cell Prolif. 58, e70113 (2025).
Ernault, A. C. et al. Knockdown of Ift88 in fibroblasts causes extracellular matrix remodeling and decreases conduction velocity in cardiomyocyte monolayers. Front. Physiol. 13, 1057200 (2022).
Liu, X. et al. Primary cilia promote cardiac fibrosis and limit heart function after myocardial infarction. Preprint at bioRxiv https://doi.org/10.64898/2026.05.30.728594 (2026).
Dong, Z. et al. Atrial fibrillation and primary cilia-associated genes: the role of CEP68. Int. J. Mol. Sci. 27, 1498 (2026).
Wang, Z. M., Gao, X. F., Zhang, J. J. & Chen, S. L. Primary cilia and atherosclerosis. Front. Physiol. 12, 640774 (2021).
Pala, R., Jamal, M., Alshammari, Q. & Nauli, S. M. The roles of primary cilia in cardiovascular diseases. Cells 7, 233 (2018).
Dinsmore, C. & Reiter, J. F. Endothelial primary cilia inhibit atherosclerosis. EMBO Rep. 17, 156–166 (2016).
Ten Dijke, P., Egorova, A. D., Goumans, M. J., Poelmann, R. E. & Hierck, B. P. TGF-β signaling in endothelial-to-mesenchymal transition: the role of shear stress and primary cilia. Sci. Signal. 5, pt2 (2012).
Luu, V. Z., Chowdhury, B., Al-Omran, M., Hess, D. A. & Verma, S. Role of endothelial primary cilia as fluid mechanosensors on vascular health. Atherosclerosis 275, 196–204 (2018).
Derderian, C., Canales, G. I. & Reiter, J. F. Seriously cilia: a tiny organelle illuminates evolution, disease, and intercellular communication. Dev. Cell. 58, 1333–1349 (2023).
Bachmann-Gagescu, R. & Sayer, J. A. Tackling ciliary specialization to understand phenotypic variability in human primary ciliopathies. J. Cell Sci. 138, jcs264177 (2025).
Garcia, H. et al. Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies. Proc. Natl. Acad. Sci. USA. 119, e2115960119 (2022).
Han, S. J. et al. Deficiency of primary cilia in kidney epithelial cells induces epithelial to mesenchymal transition. Biochem. Biophys. Res. Commun. 496, 450–454 (2018).
Hwang, S. H. et al. Tulp3 regulates renal cystogenesis by trafficking of cystoproteins to cilia. Curr. Biol. 29, 790–802.e5 (2019).
Epting, D. et al. Tulp3 deficiency results in ciliopathy phenotypes during zebrafish embryogenesis. Sci. Rep. 15, 32435 (2025).
Macarelli, V., Leventea, E. & Merkle, F. T. Regulation of the length of neuronal primary cilia and its potential effects on signalling. Trends Cell Biol. 33, 979–990 (2023).
Zhang, R. et al. Primary cilia in neural development and disease. Neurobiol. Dis. 217, 107184 (2025).
Palicharla, V. R. & Mukhopadhyay, S. Molecular and structural perspectives on protein trafficking to the primary cilium membrane. Biochem. Soc. Trans. 52, 1473–1487 (2024).
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B. & Christensen, S. T. Cellular signalling by primary cilia in development, organ function and disease. Nat. Rev. Nephrol. 15, 199–219 (2019).
Nishimura, Y., Kasahara, K., Shiromizu, T., Watanabe, M. & Inagaki, M. Primary cilia as signaling hubs in health and disease. Adv. Sci. 6, 1801138 (2019).
Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823 (2013).
Hong, R. et al. XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis. EMBO Rep. 25, 1055–1074 (2024).
Thompson, C. L., Chapple, J. P. & Knight, M. M. Primary cilia disassembly down-regulates mechanosensitive Hedgehog signalling: a feedback mechanism controlling ADAMTS-5 expression in chondrocytes. Osteoarthr. Cartil. 22, 490–498 (2014).
Rowson, D. T., Shelton, J. C., Screen, H. R. C. & Knight, M. M. Mechanical loading induces primary cilia disassembly in tendon cells via TGFβ and HDAC6. Sci. Rep. 8, 11107 (2018).
Kathem, S. H. et al. Ciliotherapy: a novel intervention in polycystic kidney disease. J. Geriatr. Cardiol. 11, 63–73 (2014).
Khan, N. A. et al. Identification of drugs that restore primary cilium expression in cancer cells. Oncotarget 7, 9975–9992 (2016).
Pala, R. et al. Ciliotherapy: remote control of primary cilia movement and function by magnetic nanoparticles. ACS Nano 13, 3555–3572 (2019).
Nam, Y. W. et al. Subtype-selective positive modulation of KCa2.3 channels increases cilia length. ACS Chem. Biol. 17, 2344–2354 (2022).
Duong Phu, M., Bross, S., Burkhalter, M. D. & Philipp, M. Limitations and opportunities in the pharmacotherapy of ciliopathies. Pharmacol. Ther. 225, 107841 (2021).
Dere, R., Perkins, A. L., Bawa-Khalfe, T., Jonasch, D. & Walker, C. L. β-Catenin links von Hippel–Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J. Am. Soc. Nephrol. 26, 553–564 (2015).
Chen, X. et al. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy. Am. J. Physiol. Ren. Physiol. 319, F1003–F1014 (2020).
Gradilone, S. A. et al. HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis. Am. J. Pathol. 184, 600–608 (2014).
Zhang, Q. Q., Zhang, W. J. & Chang, S. HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation. Front. Immunol. 14, 1168848 (2023).
Ran, J., Yang, Y., Li, D., Liu, M. & Zhou, J. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci. Rep. 5, 12917 (2015).
Gopalan, J. et al. Targeting an anchored phosphatase-deacetylase unit restores renal ciliary homeostasis. eLife 10, e67828 (2021).
Vogl, D. T. et al. Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma. Clin. Cancer Res. 23, 3307–3315 (2017).
Yee, A. J. et al. Ricolinostat plus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Lancet Oncol. 17, 1569–1578 (2016).
Miyoshi, K., Kasahara, K., Miyazaki, I. & Asanuma, M. Lithium treatment elongates primary cilia in the mouse brain and in cultured cells. Biochem. Biophys. Res. Commun. 388, 757–762 (2009).
Thompson, C. L., Wiles, A., Poole, C. A. & Knight, M. M. Lithium chloride modulates chondrocyte primary cilia and inhibits Hedgehog signaling. FASEB J. 30, 716–726 (2016).
Upadhyay, V. S., Muntean, B. S., Kathem, S. H., AbouAlaiwi, W. A. & Nauli, S. M. Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells. Front. Physiol. 5, 72 (2014).
Spasic, M. & Jacobs, C. R. Lengthening primary cilia enhances cellular mechanosensitivity. Eur. Cell. Mater. 33, 158–168 (2017).
Spasic, M., Duffy, M. P. & Jacobs, C. R. Fenoldopam sensitizes primary cilia-mediated mechanosensing to promote osteogenic intercellular signaling and whole bone adaptation. J. Bone Miner. Res. 37, 972–982 (2022).
Atkinson, K. F. et al. Dopaminergic signaling within the primary cilia in the renovascular system. Front. Physiol. 6, 103 (2015).
Mou, Y. et al. Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation. Biomed. Pharmacother. 139, 111500 (2021).
Gao, A. Y., Link, P. A., Bakri, S. J. & Haak, A. J. Dopamine receptor signaling regulates fibrotic activation of retinal pigmented epithelial cells. Am. J. Physiol. Cell Physiol. 323, C116–C124 (2022).
Haak, A. J. et al. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Sci. Transl. Med. 11, eaau6296 (2019).
Gholkar, A. A., Gimeno, T. V., Edgemon, J. E., Sim, M. S. & Torres, J. Z. MI-181 modulates cilia length and restores cilia length in cells with defective shortened cilia. ACS Chem. Biol. 19, 1733–1742 (2024).
Gholkar, A. A. et al. MI-181 enhances ciliation and cilia length in a cigarette smoke-exposed airway epithelial model. Sci. Rep. 16, 6136 (2026).
Husson, H. et al. Correction of cilia structure and function alleviates multi-organ pathology in Bardet–Biedl syndrome mice. Hum. Mol. Genet. 29, 2508–2522 (2020).
Gradilone, S. A. et al. HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res. 73, 2259–2270 (2013).
Yang, Y. et al. CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. Cell Res. 24, 1342–1353 (2014).
Wang, E. X., Turner, J. S., Brautigan, D. L. & Fu, Z. Modulation of primary cilia by alvocidib inhibition of CILK1. Int. J. Mol. Sci. 23, 8121 (2022).
Jeffries, E. P., Di Filippo, M. & Galbiati, F. Failure to reabsorb the primary cilium induces cellular senescence. FASEB J. 33, 4866–4882 (2019).
Chowdhury, P. et al. Bexarotene: a novel modulator of AURKA and the primary cilium in VHL-deficient cells. J. Cell Sci. 131, jcs219923 (2018).
Sherpa, R. T., Atkinson, K. F., Ferreira, V. P. & Nauli, S. M. Rapamycin increases length and mechanosensory function of primary cilia in renal epithelial and vascular endothelial cells. Int. Educ. Res. J. 2, 91–97 (2016).
Li, J., Kim, S. G. & Blenis, J. Rapamycin: one drug, many effects. Cell Metab. 19, 373–379 (2014).
Kim, Y. J. et al. Eupatilin rescues ciliary transition zone defects to ameliorate ciliopathy-related phenotypes. J. Clin. Invest. 128, 3642–3648 (2018).
Li, Z. et al. Eupatilin unveiled: an in-depth exploration of research advancements and clinical therapeutic prospects. J. Transl. Int. Med. 13, 104–117 (2025).
Peixoto, E. et al. HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G1022–G1033 (2020).
Ding, D. et al. Pharmacological regulation of primary cilium formation affects the mechanosensitivity of osteocytes. Calcif. Tissue Int. 107, 625–635 (2020).
Besschetnova, T. Y. et al. Identification of signaling pathways regulating primary cilium length and flow-mediated adaptation. Curr. Biol. 20, 182–187 (2010).
Abdul-Majeed, S., Moloney, B. C. & Nauli, S. M. Mechanisms regulating cilia growth and cilia function in endothelial cells. Cell. Mol. Life Sci. 69, 165–173 (2012).